Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
Add more filters










Publication year range
1.
Int Immunopharmacol ; 69: 368-372, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30776645

ABSTRACT

The relationship between inflammation and formation of reactive oxygen species (ROS) is still not completely understood and excessive inflammatory reaction is attributed to increased yet also to reduced ROS formation. To compare ROS formation in severe and low inflammation, neutrophil oxidative burst was analyzed in rheumatic patients before and during therapy with TNFα- or interleukin-6 receptor-neutralizing antibodies. Intracellular and extracellular ROS productions were evaluated on the basis of luminol- and isoluminol-enhanced chemiluminescence in isolated peripheral neutrophils. Disease activity score DAS28 and platelet to lymphocyte ratio were used as markers of arthritis activity and the intensity of systemic inflammation. Biological therapy effectively reduced the intensity of inflammation. Of the twenty-six patients studied eighteen achieved remission or low disease activity. Highly active arthritis persisted only in one patient, though prior to the therapy it was evident in all subjects tested. In patients receiving biological therapy, intracellular chemiluminescence was significantly higher than in patients before this therapy; ROS produced by neutrophils extracellularly were not affected. The increased ROS formation associated with reduced inflammation supports the need to revise the view of the role of ROS in inflammation - from toxic agents promoting inflammation towards a more complex view of ROS as regulators of immune pathways with inflammation-limiting capacity. From this perspective, the interference with neutrophil-derived oxidants may represent a new mechanism involved in the anti-inflammatory activity of biological therapy.


Subject(s)
Antibodies, Neutralizing/therapeutic use , Arthritis, Rheumatoid/drug therapy , Immunotherapy/methods , NADPH Oxidases/metabolism , Neutrophils/physiology , Adult , Aged , Female , Humans , Inflammation , Male , Middle Aged , Oxidative Stress , Reactive Oxygen Species/metabolism , Receptors, Interleukin-6/immunology , Tumor Necrosis Factor-alpha/immunology , Young Adult
2.
FEMS Yeast Res ; 19(2)2019 03 01.
Article in English | MEDLINE | ID: mdl-30689830

ABSTRACT

Candida glabrata is a second most common human opportunistic pathogen which causes superficial but also life-threatening systemic candidosis. According to the localisation of mannans and mannoproteins in the outermost layer of the cell wall, mannan detection could be one of the first steps in the cell recognition of Candida cells by the host innate immune system. Mannans from the cell wall provide important immunomodulatory activities, comprising stimulation of cytokine production, induction of dendritic cells (DCs) maturation and T-cell immunity. The model of DCs represents a promising tool to study immunomodulatory interventions throughout the vaccine development. Activated DCs induce, activate and polarise T-cell responses by expression of distinct maturation markers and cytokines regulating the adaptive immune responses. In addition, they are uniquely adept at decoding the fungus-associated information and translate it in qualitatively different T helper responses. We find out, that C. glabrata mannan is able to induce proliferation of splenocytes and to increase the production of TNF-α and IL-4. Next, increased the expression of co-stimulatory molecules CD80 and CD86 and the proportion of CD4+CD25+ and CD4+CD28+ T cells during in vitro stimulation of splenocytes. Reported results provide C. glabrata mannan capability to modulate cytokine production, DCs activation and antigen presentation activity, influencing T-cell phenotype in response to stimulation.


Subject(s)
Candida glabrata/immunology , Cytokines/metabolism , Dendritic Cells/immunology , Immunity, Innate , Immunologic Factors/metabolism , Mannans/metabolism , T-Lymphocytes/immunology , Animals , Cell Proliferation/drug effects , Cells, Cultured , Mice
3.
Interdiscip Toxicol ; 10(2): 52-55, 2017 Oct.
Article in English | MEDLINE | ID: mdl-30123037

ABSTRACT

Infectious complications, resulting from reduced activity of immune cells, are the most severe and common adverse effects of biological therapy. This study analyzed the effect of biological therapy on blood phagocytes, focusing on the formation of reactive oxygen species (ROS), an important factor in the defence against invading pathogens. Intra- and extracellular ROS production were recorded separately, on the basis of luminol and isoluminol chemiluminescence in patients treated with antibodies against tumor necrosis factor-α or against interleukin-6 receptor. In comparison to healthy donors or to rheumatic patients treated with classical immunosuppressive drugs, biological therapy increased ROS formation in both compartments. This indicates that the anti-microbial activity of blood phagocytes was not reduced by TNFα- or IL-6-neutralizing therapy, at least in terms of ROS. The method presented does not require blood fractionation, which could modify activity of phagocytes and cause loss of some subpopulations of these cells. The technique is simple, requires microliter volumes of blood and is thus well applicable to clinical studies.

4.
Interdiscip Toxicol ; 10(2): 56-60, 2017 Oct.
Article in English | MEDLINE | ID: mdl-30123038

ABSTRACT

In this study we investigated the effect of five therapeutically used drugs and four natural polyphenolic compounds on the mechanism of oxidative burst of human neutrophils concerning their participation in the generation of reactive oxygen species (ROS). The compounds investigated decreased the oxidative burst of whole blood in the rank order of potency: N-feruloylserotonin > quercetin > curcumin > arbutin > dithiaden > carvedilol. The generation of intracellular reactive oxygen species in isolated neutrophils decreased in the same rank order, while carvedilol was ineffective. Scavenging of extracellular oxygen radicals followed the rank order of potency: N-feruloylserotonin > curcumin > quercetin > dithiaden. Arbutin and carvedilol had no effect. All compounds tested increased the activity of caspase-3 in cell-free system indicating a positive effect on apoptosis of neutrophils. Activation of protein kinase C was significantly decreased by dithiaden, curcumin, quercetin and N-feruloylserotonin. Carvedilol, dithiaden, quercetin and arbutin reduced activated neutrophil myeloperoxidase release more significantly compared with their less pronounced effect on superoxide generation The presented results are indicative of pharmacological intervention with neutrophils in pathological processes. Of particular interest was the effect of natural compounds. Intracellular inhibition of oxidative burst in isolated neutrophils by the drugs tested and natural antioxidants has to be further analysed since ROS play an important role in immunological responses of neutrophils.

5.
Cell Microbiol ; 18(9): 1294-307, 2016 09.
Article in English | MEDLINE | ID: mdl-27310441

ABSTRACT

Synthetically prepared bovine serum albumin (BSA) conjugate of linear ß-(1 → 3)-nonaglucoside ligand (G9) has been applied as a biological response immunomodulator in vivo and ex vivo. Active immunization of Balb/c mice revealed effective induction of specific humoral responses in comparison with Candida ß-D-glucan and Candida whole cells. Induced post-vaccination serum exhibited a growth-inhibition effect on the multi-azole-resistant clinical strain Candida albicans CCY 29-3-164 in experimental mucocutaneous infection ex vivo. Evaluation of immune cell proliferation and the cytotoxic potential of the G9-ligand has revealed its bioavailability and an immunostimulative effect in vaccination-sensitized Balb/c mice splenocytes and RAW 264.7 macrophages.


Subject(s)
Candida albicans/immunology , Candidiasis/prevention & control , Fungal Polysaccharides/immunology , Animals , Antibodies, Fungal/blood , Antigens, Fungal/immunology , Candidiasis/blood , Candidiasis/microbiology , Cell Count , Cell Proliferation , Female , Glucosides/immunology , Hyphae/immunology , Immunity, Humoral , Mice , Mice, Inbred BALB C , RAW 264.7 Cells , Vaccination
6.
Macromol Biosci ; 16(8): 1200-11, 2016 08.
Article in English | MEDLINE | ID: mdl-27150385

ABSTRACT

Poly(2-alkenyl-2-oxazoline)s are promising functional polymers for a variety of biomedical applications, such as drug delivery systems, peptide conjugates, or gene delivery. In this study, poly(2-isopropenyl-2-oxazoline) (PIPOx) is prepared through free-radical polymerization initiated with azobisisobutyronitrile. Reactive 2-oxazoline units in the side chain support an addition reaction with different compounds containing a carboxylic group, which facilitates the preparation of polymers labeled with two different fluorescent dyes. The cytotoxicities of 2-oxazoline monomers, PIPOx, and fluorescently labeled PIPOx are evaluated in vitro using an 3-(4,5-Dimethyldiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and ex vivo using a cell proliferation assay with adenosine triphosphate bioluminescence. The cell uptake of labeled PIPOx is used to determine the colocalization of PIPOx with cell organelles that are part of the endocytic pathway. For the first time, it is shown that poly(2-isopropenyl-2-oxazoline) is a biocompatible material and is suitable for biomedical applications; further, its immunomodulative properties are evaluated.


Subject(s)
Biocompatible Materials/pharmacology , Immunomodulation/drug effects , Oxazoles/pharmacology , Polymers/pharmacology , Polypropylenes/pharmacology , 3T3 Cells , Animals , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Cell Death/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Endocytosis/drug effects , Fibroblasts/cytology , Mice , Mice, Inbred BALB C , Microscopy, Confocal , Organelles/drug effects , Organelles/metabolism , Oxazoles/chemical synthesis , Oxazoles/chemistry , Polymers/chemical synthesis , Polymers/chemistry , Polypropylenes/chemical synthesis , Polypropylenes/chemistry , Spectrometry, Fluorescence , Spleen/cytology
7.
Pharmacology ; 97(3-4): 138-45, 2016.
Article in English | MEDLINE | ID: mdl-26745858

ABSTRACT

Equol (7,4'-dihydroxy-isoflavan, or 4',7-isoflavandiol) is a chroman derivative produced by intestinal bacteria in response to soy isoflavone intake in some, but not in all, humans. Equol shows strong anti-oxidant, anti-estrogenic, anti-cancerous and anti-inflammatory properties. The antioxidative capacity of equol has recently received considerable attention, and it has been used for preventing and treating several diseases. We investigated the effect of equol on human neutrophils, extra- and intracellular formation of oxidants, the phosphorylation of protein regulating NADPH oxidase and its effect on apoptosis. Neutrophils, isolated from blood from healthy subjects, were tested upon activation with various stimulants, proper for reactive oxygen species (ROS) production and treated by equol. Equol has the ability to reduce the toxic action of neutrophils. With increasing concentrations, equol decreased the amount of oxidants produced by neutrophils both extra- and intracellularly. The phosphorylation of p40(phox) (a component of NADPH oxidase, responsible for the assembly of functional oxidase in intracellular membranes) was reduced in the presence of equol. The experiments showed that equol did not change the number of viable, apoptotic or dead neutrophils significantly in all concentrations used. These results indicate the promising effect of equol in the operation of ROS in different mechanisms in the model of inflammation.


Subject(s)
Antioxidants/pharmacology , Equol/pharmacology , Neutrophils/drug effects , Adult , Cell Survival/drug effects , Humans , Male , Middle Aged , NADPH Oxidases/metabolism , Neutrophils/metabolism , Phosphorylation/drug effects , Reactive Oxygen Species/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Young Adult
8.
Int Immunopharmacol ; 28(1): 175-81, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26071217

ABSTRACT

Hydroxychloroquine is used in the therapy of rheumatoid arthritis or lupus erythematosus. Although these diseases are often accompanied by activation of neutrophils, there are still few data relating to the impact of hydroxychloroquine on these cells. We investigated the effect of orally administered hydroxychloroquine on neutrophil oxidative burst in rats with adjuvant arthritis. In human neutrophils, extra- and intracellular formation of oxidants, mobilisation of intracellular calcium and the phosphorylation of proteins regulating NADPH oxidase assembly were analysed. Administration of hydroxychloroquine decreased the concentration of oxidants in blood of arthritic rats. The inhibition was comparable with the reference drug methotrexate, yet it was not accompanied by a reduction in neutrophil count. When both drugs were co-applied, the effect became more pronounced. In isolated human neutrophils, treatment with hydroxychloroquine resulted in reduced mobilisation of intracellular calcium, diminished concentration of external oxidants and in decreased phosphorylation of Ca(2+)-dependent protein kinase C isoforms PKCα and PKCßII, which regulate activation of NADPH oxidase on plasma membrane. On the other hand, no reduction was observed in intracellular oxidants or in the phosphorylation of p40(phox) and PKCδ, two proteins directing the oxidase assembly to intracellular membranes. Hydroxychloroquine reduced neutrophil-derived oxidants potentially involved in tissue damage and protected those capable to suppress inflammation. The observed effects may represent a new mechanism involved in the anti-inflammatory activity of this drug.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Extracellular Space/metabolism , Hydroxychloroquine/pharmacology , Neutrophils/metabolism , Oxidants/metabolism , Adult , Animals , Arthritis, Experimental/pathology , Calcium Signaling/drug effects , Humans , In Vitro Techniques , Leukocyte Count , Male , Methotrexate/pharmacology , Middle Aged , NADPH Oxidases/metabolism , Neutrophils/drug effects , Phosphorylation , Protein Kinase C/drug effects , Protein Kinase C/metabolism , Rats , Rats, Inbred Lew , Respiratory Burst/drug effects , Young Adult
9.
Gen Physiol Biophys ; 34(2): 209-16, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25730898

ABSTRACT

Antihistamines of the H1and H3/H4groups interfere with oxidative burst of human professional phagocytes in vitro. In the concentration of 10 µM, H1antihistamines of the 1st and 2nd generation inhibited oxidative burst of human neutrophils in the rank order of potency: dithiaden > loratadine > brompheniramine > chlorpheniramine > pheniramine. Of the H1antihistamines, the most effective was dithiaden in suppressing oxidative burst of whole human blood and dose-dependently the chemiluminescence of isolated neutrophils at extra- and intracellular level. Inhibition of free oxygen radical generation in isolated neutrophils by dithiaden resulted from the inhibition of protein kinase C activation. The potentiation of recombinant caspase-3 by dithiaden is supportive of the antiinflammatory effect of dithiaden and suggestive of increasing the apoptosis of professional phagocytes. Of the H3/H4antihistamines, the most effective was JNJ7777120 in decreasing chemiluminescence in whole blood and also at extra- and intracellular sites of isolated neutrophils. JNJ 10191584 and thioperamide were less effective and the latter significantly potentiated free oxygen radical generation intracellularly. The results demonstrated that, compared with the H3/H4antihistamines investigated, H1antihistamines were much more potent in inhibiting free oxygen radical generation in human professional phagocytes. This finding should be taken into account therapeutically.


Subject(s)
Histamine Antagonists/administration & dosage , Neutrophil Activation/physiology , Neutrophils/physiology , Phagocytes/physiology , Respiratory Burst/physiology , Adult , Dose-Response Relationship, Drug , Humans , Male , Neutrophil Activation/drug effects , Neutrophils/drug effects , Phagocytes/drug effects , Respiratory Burst/drug effects
10.
Oxid Med Cell Longev ; 2014: 706269, 2014.
Article in English | MEDLINE | ID: mdl-24672638

ABSTRACT

Resveratrol-3,5,4'-trihydroxystilbene-possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 µM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 µM significantly decreased PMA-induced phosphorylation of PKC α/ß II. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.


Subject(s)
Phagocytes/metabolism , Respiratory Burst/drug effects , Stilbenes/pharmacology , Animals , Cell Line , Cell Separation , Cell Survival/drug effects , Free Radical Scavengers/metabolism , Humans , Lipid Peroxidation/drug effects , Luminescent Measurements , Luminol/metabolism , Mice , Neutrophils/drug effects , Neutrophils/metabolism , Nitric Oxide Synthase Type II/metabolism , Nitrites/metabolism , Phagocytes/drug effects , Phagocytes/enzymology , Protein Kinases/metabolism , Reactive Oxygen Species/metabolism , Resveratrol , Tetradecanoylphorbol Acetate/pharmacology , Thiobarbituric Acid Reactive Substances/metabolism
11.
Life Sci ; 100(1): 67-72, 2014 Mar 28.
Article in English | MEDLINE | ID: mdl-24530738

ABSTRACT

AIMS: The diverse physiological functions of histamine are mediated through distinct histamine receptors. In this study we investigated the role of H2R and H4R in the effects of histamine on the production of reactive oxygen species by phagocytes in whole blood. MAIN METHODS: Changes in reactive oxygen species (ROS) production by whole blood phagocytes after treatment with histamine, H4R agonists (4-methylhistamine, VUF8430), H2R agonist (dimaprit) and their combinations with H4R antagonist (JNJ10191584) and H2R antagonist (ranitidine) were determined using the chemiluminescence (CL) assay. To exclude the direct scavenging effects of the studied compounds on the CL response, the antioxidant properties of all compounds were measured using several methods (TRAP, ORAC, and luminol-HRP-H2O2 based CL). KEY FINDINGS: Histamine, 4-methylhistamine, VUF8430 and dimaprit inhibited the spontaneous and OZP-activated whole blood CL in a dose-dependent manner. On the other hand, only VUF8430 was able to inhibit PMA-activated whole blood CL. Ranitidine, but not JNJ10191584, completely reduced the effects of histamine, 4-methylhistamine and dimaprit. The direct scavenging ability of tested compounds was negligible. SIGNIFICANCE: Our results demonstrate that the inhibitory effects of histamine on ROS production in whole blood phagocytes were caused by H2R. Our results also suggest that H4R agonists in concentrations higher than 10(-6)M may also influence ROS production via binding to H2R.


Subject(s)
Histamine/physiology , Phagocytes/metabolism , Reactive Oxygen Species/blood , Receptors, G-Protein-Coupled/metabolism , Receptors, Histamine H2/metabolism , Receptors, Histamine/metabolism , Benzimidazoles/pharmacology , Dimaprit/pharmacology , Guanidines/pharmacology , Histamine Agonists/pharmacology , Humans , Male , Methylhistamines/pharmacology , Phagocytes/drug effects , Receptors, G-Protein-Coupled/agonists , Receptors, Histamine H4 , Thiourea/analogs & derivatives , Thiourea/pharmacology
12.
Oxid Med Cell Longev ; 2013: 136570, 2013.
Article in English | MEDLINE | ID: mdl-24349608

ABSTRACT

To specify the site of action of the synthetic coumarin derivatives 7-hydroxy-3-(4'-hydroxyphenyl) coumarin (HHC) and 7-hydroxy-3-(4'-hydroxyphenyl) dihydrocoumarin (HHDC), we evaluated their effects on extra- and intracellular reactive oxygen species (ROS) formation in phorbol-myristate-13-acetate (PMA) stimulated human neutrophils. We studied also the effects of HHC and HHDC on possible molecular mechanisms which participate in the activation of NADPH oxidase, that is, on PKC activity, on phosphorylation of some PKC isoforms (α, ßII, and δ), and on phosphorylation of the NADPH oxidase subunit p40(phox). Without affecting cytotoxicity, both coumarines tested were effective inhibitors/scavengers of ROS produced by neutrophils on extracellular level. HHC markedly diminished oxidant production and also, intracellularly, decreased PKC activity and partly phosphorylation of PKCα, ßII. On the other hand, we did not observe any effect of coumarin derivatives on phosphorylation of PKC δ and on phosphorylation of the NADPH oxidase subunit p40(phox), which were suggested to be involved in the PMA-dependent intracellular activation process. In agreement with our previous findings, we assume that the different molecular structures of HHC and HHDC with their different physicochemical and free radical scavenging characteristics are responsible for their diverse effects on the parameters tested.


Subject(s)
Coumarins/pharmacology , Neutrophils/drug effects , Adenosine Triphosphate/metabolism , Adult , Cell Death/drug effects , Cell-Free System , Coumarins/chemistry , Extracellular Space/drug effects , Extracellular Space/metabolism , Humans , Inhibitory Concentration 50 , Intracellular Space/drug effects , Intracellular Space/metabolism , Isoenzymes/metabolism , Kinetics , Luminescent Measurements , Male , Middle Aged , Neutrophil Activation/drug effects , Neutrophils/cytology , Neutrophils/enzymology , Phosphoproteins/metabolism , Phosphorylation/drug effects , Reactive Oxygen Species/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Young Adult
13.
Biomed Res Int ; 2013: 106041, 2013.
Article in English | MEDLINE | ID: mdl-24195064

ABSTRACT

It has been demonstrated that pterostilbene inhibits reactive oxygen species production in neutrophils in vitro. However, little is known about its effects on neutrophils during inflammation in vivo. In this study, the effect of pterostilbene on neutrophil activity was investigated in experimental arthritis model. Lewis rats were injected by a single intradermal injection of heat-killed Mycobacterium butyricum in Freund's adjuvant to develop arthritis. Another group of arthritic animals received pterostilbene 30 mg/kg, daily, p.o. The number and activity of neutrophils in blood were measured on a weekly basis during the whole experiment. Moreover, the total radical trapping potential in plasma was measured at the end of the experiment. In the pterostilbene treated arthritic group, the treatment significantly lowered the number of neutrophils in blood on days 14 and 21 without significant downregulation of neutrophil oxidative burst. Pterostilbene nonsignificantly increased total radical trapping potential in arthritic animals. These results indicate that the promising effects of pterostilbene on reactive oxygen species operate by different mechanisms in vitro and in the animal model of inflammation. In conclusion, the positive effects of pterostilbene in the model of arthritis may be attributed to regulation of neutrophil number.


Subject(s)
Arthritis, Experimental/drug therapy , Arthritis, Experimental/pathology , Neutrophils/drug effects , Stilbenes/pharmacology , Stilbenes/therapeutic use , Animals , Cross-Priming/drug effects , Cross-Priming/immunology , Disease Models, Animal , Down-Regulation/drug effects , Leukocyte Count , Male , Neutrophils/cytology , Neutrophils/pathology , Peroxides/metabolism , Rats , Rats, Inbred Lew , Reactive Oxygen Species/metabolism , Stilbenes/chemistry
14.
Oxid Med Cell Longev ; 2013: 136539, 2013.
Article in English | MEDLINE | ID: mdl-24288583

ABSTRACT

Neutrophils are able to release cytotoxic substances and inflammatory mediators, which, along with their delayed apoptosis, have a potential to maintain permanent inflammation. Therefore, treatment of diseases associated with chronic inflammation should be focused on neutrophils; formation of reactive oxygen species and apoptosis of these cells represent two promising targets for pharmacological intervention. Piceatannol, a naturally occurring stilbenoid, has the ability to reduce the toxic action of neutrophils. This substance decreased the amount of oxidants produced by neutrophils both extra- and intracellularly. Radicals formed within neutrophils (fulfilling a regulatory role) were reduced to a lesser extent than extracellular oxidants, potentially dangerous for host tissues. Moreover, piceatannol did not affect the phosphorylation of p40(phox)-a component of NADPH oxidase, responsible for the assembly of functional oxidase in intracellular (granular) membranes. The stilbenoid tested elevated the percentage of early apoptotic neutrophils, inhibited the activity of protein kinase C (PKC)-the main regulatory enzyme in neutrophils, and reduced phosphorylation of PKC isoforms α , ß II, and δ on their catalytic region. The results indicated that piceatannol may be useful as a complementary medicine in states associated with persisting neutrophil activation and with oxidative damage of tissues.


Subject(s)
Apoptosis/drug effects , Biological Products/pharmacology , Neutrophils/cytology , Neutrophils/enzymology , Protein Kinase C/metabolism , Stilbenes/pharmacology , Adult , Biological Products/chemistry , Cell Separation , Humans , Luminescent Measurements , Male , Middle Aged , Neutrophils/drug effects , Phosphoproteins/metabolism , Phosphorylation/drug effects , Respiratory Burst/drug effects , Stilbenes/chemistry , Young Adult
15.
Interdiscip Toxicol ; 5(2): 59-64, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23118588

ABSTRACT

Prolonged or excessive formation and liberation of cytotoxic substances from neutrophils intensifies inflammation and the risk of tissue damage. From this perspective, administration of substances which are able to reduce activity of neutrophils and to enhance apoptosis of these cells may improve the therapy of pathological states connected with persistent inflammation. In this short review, neutrophil oxidative burst and apoptosis are presented as potential targets for pharmacological intervention. Effects of natural polyphenols (resveratrol, pterostilbene, pinosylvin, piceatannol, curcumin, N-feruloylserotonin) are summarised, considering the ability of these compounds to affect inflammation and particularly neutrophil activity. The intended neutrophil inhibition is introduced as a part of a new strategy for pharmacological modulation of chronic inflammatory processes, focused on supporting innate anti-inflammatory mechanisms and enhancing resolution of inflammation.

16.
Interdiscip Toxicol ; 5(2): 65-70, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23118589

ABSTRACT

The study provides new information on the effect of natural polyphenols (derivatives of stilbene - resveratrol, pterostilbene, pinosylvin and piceatannol and derivatives of ferulic acid - curcumin, N-feruloylserotonin) on the activity of human neutrophils in influencing oxidative burst. All the polyphenols tested were found to reduce markedly the production of reactive oxygen species released by human neutrophils on extra-and intracellular levels as well as in cell free system. Moreover, pinosylvin, curcumin, N-feruloylserotonin and resveratrol decreased protein kinase C activity involved in neutrophil signalling and reactive oxygen species production. Our results suggest that due to their anti-neutrophil activity, the polyphenols tested might be attractive candidates in therapeutic development.

17.
Interdiscip Toxicol ; 5(2): 76-80, 2012 Jun.
Article in English | MEDLINE | ID: mdl-23118591

ABSTRACT

Chronic inflammatory diseases, e.g. rheumatoid arthritis or cystic fibrosis, are characterised by neutrophil infiltration in inflamed tissues. Dysregulated neutrophil death may contribute to the pathogenesis of diseases where neutrophils play a role. Stilbene derivatives are reported to activate apoptosis in different cell lines. Neutrophils from healthy volunteers were incubated in vitro with resveratrol, pterostilbene, pinosylvin or piceatannol (1-100 µmol/l), and cytotoxicity and apoptosis were measured by luminometry and flow cytometry, respectively. Enhancement and/or inhibition of human recombinant caspase-3 enzyme activity were measured by luminometry. None of the stilbene derivatives tested increased ATP liberation from human neutrophils, thus showing no direct cytotoxicity effect. Resveratrol and piceatannol (100 µmol/l) treated neutrophils had a higher rate of apoptosis compared to non-treated cells. Pterostilbene and pinosylvin (1 µmol/l), yet not resveratrol or piceatannol, increased the activity of caspase-3. However in the concentration of 100 µmol/l, all stilbene derivatives tested inhibited caspase-3 activity. Their effects on human neutrophil apoptosis differed according to the structure of the molecule. Additional studies are required to get insight into the mechanisms involved in the effects of the substances tested on neutrophil viability.

18.
Acta Pharmacol Sin ; 33(10): 1285-92, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22842731

ABSTRACT

AIM: To investigate the effects of the naturally occurring stilbenoid pinosylvin on neutrophil activity in vitro and in experimental arthritis, and to examine whether protein kinase C (PKC) activation served as an assumed target of pinosylvin action. METHODS: Fresh human blood neutrophils were isolated. The oxidative burst of neutrophils was evaluated on the basis of enhanced chemiluminescence. Neutrophil viability was evaluated with flow cytometry, and PKC phosphorylation was assessed by Western blotting analysis. Adjuvant arthritis was induced in Lewis rats with heat-killed Mycobacterium butyricum, and the animals were administered with pinosylvin (30 mg/kg, po) daily for 21 d after arthritis induction. RESULTS: In isolated human neutrophils, pinosylvin (10 and 100 µmol/L) significantly decreased the formation of oxidants, both extra- and intracellularly, and effectively inhibited PKC activation stimulated by phorbol myristate acetate (0.05 µmol/L). The inhibition was not due to neutrophil damage or increased apoptosis. In arthritic rats, the number of neutrophils in blood was dramatically increased, and whole blood chemiluminescence (spontaneous and PMA-stimulated) was markedly enhanced. Pinosylvin administration decreased the number of neutrophils (from 69 671 ± 5588/µL to 51 293 ± 3947/µL, P=0.0198) and significantly reduced the amount of reactive oxygen species in blood. CONCLUSION: Pinosylvin is an effective inhibitor of neutrophil activity, and is potentially useful as a complementary medicine in states associated with persistent inflammation.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Apoptosis/drug effects , Arthritis, Experimental/drug therapy , Neutrophil Activation/drug effects , Neutrophils/drug effects , Protein Kinase C/metabolism , Respiratory Burst/drug effects , Stilbenes/therapeutic use , Adult , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Arthritis, Experimental/blood , Arthritis, Experimental/enzymology , Arthritis, Experimental/immunology , Blotting, Western , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Flow Cytometry , Humans , Leukocyte Count , Luminescent Measurements , Male , Middle Aged , Neutrophils/cytology , Neutrophils/metabolism , Pinus sylvestris/chemistry , Rats , Rats, Inbred Lew , Reactive Oxygen Species/metabolism , Stilbenes/administration & dosage , Stilbenes/pharmacology , Young Adult
19.
Pharmacol Rep ; 63(3): 790-8, 2011.
Article in English | MEDLINE | ID: mdl-21857090

ABSTRACT

N-feruloylserotonin (N-f-5HT) isomers, isolated from seeds of Leuzea carthamoides (Wild) DC, inhibited dose-dependent oxidative burst in human whole blood and isolated neutrophils in vitro, which were measured by luminol- and/or isoluminol-enhanced chemiluminescence in the following rank order of stimuli: PMA > OpZ > calcium ionophore A23187. In isolated neutrophils that were stimulated with PMA, N-f-5HT isomers were effective against extracellular and intracellular reactive oxygen species. Liberation of ATP, analysis of apoptosis, and recombinant caspase-3 activity revealed that N-f-5HT isomers, used in concentrations up to 100 µM, did not alter the viability and integrity of isolated neutrophils. Western blot analysis documented that in concentrations of 10 and 100 µM, N-f-5HT isomers significantly decreased PMA-induced phosphorylation of PKC α/ß II. The results suggest that N-f-5HT isomers are an effective, naturally occurring substance with a potent pharmacological effect on the oxidative burst of human neutrophils. It should be further investigated for its pharmacological activity against oxidative stress in ischemia-reperfusion, inflammation and other pathological conditions.


Subject(s)
Neutrophils/drug effects , Protein Kinase C/metabolism , Respiratory Burst/drug effects , Serotonin/analogs & derivatives , Adult , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Isomerism , Leuzea/chemistry , Luminescent Measurements , Male , Middle Aged , Neutrophils/metabolism , Phosphorylation/drug effects , Reactive Oxygen Species/metabolism , Seeds , Serotonin/chemistry , Serotonin/isolation & purification , Serotonin/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Young Adult
20.
Interdiscip Toxicol ; 4(1): 11-4, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21577278

ABSTRACT

Novel strategies of antiinflammatory therapy are based upon pharmacological agents capable to enhance the resolution - i.e. the termination of the beneficial inflammation before it may turn into an adverse chronic stage. In contrast to the current therapy, which antagonises the formation of proinflammatory mediators, the "proresolving" therapy promotes natural antiinflammatory processes. It is likely that several drugs and phytochemicals would act in this way, but this point has not been investigated and thus might be totally overlooked. In this paper, effects of curcumin (diferuloylmethane) were analysed, considering the ability of this natural compound to affect resolution of inflammation through modulation of its important inputs - activity and apoptosis of neutrophils. The presented data indicate that, besides its well-known ability to suppress mechanisms engaged at the onset and progression of inflammation, curcumin could support resolution of inflammation through decreased activity and enhanced apoptosis of neutrophils. This substance decreased the formation of oxidants in neutrophils, both under in vitro conditions and after oral administration to arthritic rats. Moreover, curcumin accelerated spontaneous apoptosis of neutrophils, as indicated by increased externalisation of phosphatidylserine, by intercalation of propidium iodide and by enhanced activity of the executioner caspase-3.

SELECTION OF CITATIONS
SEARCH DETAIL
...